eLife · 2017 · 112 citations · 43 references
Life SciencesNeurobiologyNeuroscienceAgingMolecular NeurobiologyMolecular NeuroscienceMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeurotransmissionParkinson DiseaseParkinsonian DisordersAge-related Neurodegenerative MechanismsAging-related Synaptic DeclineDopamine TransportersDopaminergic Synaptic DysfunctionGlutamatergic SynapsesLrrk2 MutationsNigrostriatal Dopamine SystemStriatal Dopamine Function
LRRK2 mutations produce end-stage Parkinson's disease (PD) with reduced nigrostriatal dopamine, whereas, asymptomatic carriers have increased dopamine turnover and altered brain connectivity. LRRK2 pathophysiology remains unclear, but reduced dopamine and mitochondrial abnormalities occur in aged G2019S mutant knock-in (GKI) mice. Conversely, cultured GKI neurons exhibit increased synaptic transmission. We assessed behavior and synaptic glutamate and dopamine function across a range of ages. Young GKI mice exhibit more vertical exploration, elevated glutamate and dopamine transmission, and aberrant D2-receptor responses. These phenomena decline with age, but are stable in littermates. In young GKI mice, dopamine transients are slower, independent of dopamine transporter (DAT), increasing the lifetime of extracellular dopamine. Slowing of dopamine transients is observed with age in littermates, suggesting premature ageing of dopamine synapses in GKI mice. Thus, GKI mice exhibit early, but declining, synaptic and behavioral phenotypes, making them amenable to investigation of early pathophysiological, and later parkinsonian-like, alterations. This model will prove valuable in efforts to develop neuroprotection for PD.
43
Overdependence on degraded gist memory in Alzheimer's disease.
Neuropsychology · 2006 · 4.7K citations
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Jeffrey H. Kordower, C. Warren Olanow, Hemraj B. Dodiya et al. · Brain · 2013 · 1.3K citations · Full text
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
Irene Litvan, Dag Aarsland, Charles H. Adler et al. · Movement Disorders · 2011 · 799 citations · Full text
Medicine, Neurology, Neuroscience +17